Projects per year
Fingerprint
Dive into the research topics where Yana Dekempeneer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
Research output
-
Investigating immune activation upon beta targeted radionuclide therapy using anti-CD20 single domain antibody fragments in melanoma
Ertveldt, T., Dekempeneer, Y., De Beck, L., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Devoogdt, N., Keyaerts, M., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., 7 Feb 2020, p. page 79. 1 p.Research output: Unpublished contribution to conference › Poster
-
Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 Apr 2020, In : Cancers. 12, 4, 1017.Research output: Contribution to journal › Article
Open AccessFile11 Citations (Scopus)88 Downloads (Pure) -
Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer.
Dekempeneer, Y., Caveliers, V., Ooms, M., Maertens, D., Gysemans, M., Lahoutte, T., Xavier, C., Lecocq, Q., Maes, K., Covens, P., Miller, B. W., Bruchertseifer, F., Morgenstern, A., Cardinaels, T. & D'Huyvetter, M., 8 Sep 2020, In : Molecular Pharmaceutics. 17, 9, p. 3553-3566 14 p.Research output: Contribution to journal › Article
7 Citations (Scopus) -
Combining Bismuth-213 with Nanobodies: Finding the Perfect Match for Targeted Alpha Therapy
Dekempeneer, Y., Caveliers, V., D'Huyvetter, M., Maertens, D., Gysemans, M., Ooms, M., Lahoutte, T., Xavier, C., Bruchertseifer, F., Morgenstern, A. & Cardinaels, T., 23 Mar 2019, Journal of Medical Imaging and Radiation Sciences. 1 ed. Elsevier, Vol. 50. p. S7-S8 2 p.Research output: Chapter in Book/Report/Conference proceeding › Conference paper
Open Access -
Does targeted radionuclide therapy using 177Lutetium induce immune activation upon treatment?
Ertveldt, T., Krasniqi, A., Keyaerts, M., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., De Beck, L., Dekempeneer, Y., Devoogdt, N., D'Huyvetter, M. & Breckpot, K., 7 Jun 2019.Research output: Unpublished contribution to conference › Poster
Prizes
-
INCOVO Price Cancer Research
Yana Dekempeneer (Recipient), Dec 2016
Prize: Prize (including medals and awards)
-
Junior Travel Grant TAT 2017
Yana Dekempeneer (Recipient), 30 Mar 2017
Prize: Prize (including medals and awards)
-
Travel Grant EANM 2017
Yana Dekempeneer (Recipient), 22 Oct 2017
Prize: Prize (including medals and awards)
-
Travel Grant Research Stay Gothenburg
Yana Dekempeneer (Recipient), 1 May 2016
Prize: Prize (including medals and awards)
Activities
-
2020-70
Matthias D'Huyvetter (Supervisor), Claudia Mebis (Contributor), Marijse Hulsbosch (Contributor), Yana Dekempeneer (Contributor)2020Activity: Other
-
Labeling of an anti-HER2 nanobody with the α-particle emitter bismuth-213: in vitro and in vivo evaluation
Yana Dekempeneer (Speaker)11 May 2019Activity: Talk or presentation › Talk or presentation at a conference
-
Combining bismuth-213 with Nanobodies: finding the match for Targeted Alpha Radionuclide Therapy
Yana Dekempeneer (Speaker)1 Apr 2019 → 5 Apr 2019Activity: Talk or presentation › Talk or presentation at a conference
-
11th International Symposium on Targeted-Alpha-Therapy
Yana Dekempeneer (Participant)1 Apr 2019 → 5 Apr 2019Activity: Participating in or organising an event › Participation in conference
-
European Molecular Imaging Meeting - EMIM 2018
Carlien Geldof (Organiser), Yana Dekempeneer (Organiser)21 Mar 2018Activity: Participating in or organising an event › Participation in conference
Press / Media
-
-
Q&A: Treating cancer with precisely targeted drugs
3/02/17
1 item of Media coverage
Press/Media: Research
-
-
Jonge wetenschapster krijgt beurs: Yana onderzoekt of kamelen kanker kunnen helpen bestrijden (Het Nieuwsblad)
28/11/15
1 item of Media coverage
Press/Media: Research
-
Incovo steunt baanbrekend kankeronderzoek van jonge, Zemstse wetenschapper
14/12/16
1 item of Media coverage
Press/Media: Research
Thesis
-
Radiolabeling of nanobodies with Bismuth-213 for Targeted Alpha Therapy
Author: Caveliers, V., Rens, L. & Dekempeneer, Y., 5 Sep 2019Student thesis: Master's Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Author: Ballet, S. & Dekempeneer, Y., Sep 2020Supervisor: Ballet, S. (Jury)
Student thesis: Doctoral Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Author: Dekempeneer, Y., Caveliers, V., D'Huyvetter, M., Hernot, S. & Devoogdt, N., Sep 2020Student thesis: Doctoral Thesis
-
TARGETED ALPHA THERAPY WITH SINGLE-DOMAIN ANTIBODY FRAGMENTS, A NOVEL CANCER TREATMENT
Author: Ballet, S. & Dekempeneer, Y., Jun 2020Supervisor: Ballet, S. (Jury)
Student thesis: Doctoral Thesis
-
Towards a new, safe adjuvant: The effects of farnesyl pyrophosphate in the adaptive immune response
Author: De Kempeneer, Y., Annaert, W. & Liu, W., 2015Student thesis: Master's Thesis